In conclusion, IFNα protein positivity was present in a subgroup of patients with early untreated RA and associated with double-positivity for RF and ACPA, but not with disease activity, and did not predict remission 24 weeks after treatment initiation. This evidence concerns the gene IFNA1 and rheumatoid arthritis.